Oxygenta Pharmaceutical Investor Relations Material
Latest events
Q1 25/26
20 Aug, 2025
Q4 24/25
30 May, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Oxygenta Pharmaceutical Limited
Access all reports
Oxygenta Pharmaceutical Limited is a pharmaceutical company engaged in the manufacturing of active pharmaceutical ingredients (APIs) and intermediates. The company focuses on the production of bulk drugs used in various therapeutic segments, supporting pharmaceutical formulation manufacturers. Its operations include chemical synthesis, quality control, and adherence to regulatory standards for domestic and export markets. The company is headquartered in Visakhapatnam, India, and its shares are listed on the BSE.
Latest articles
)
Verisure: Security Leader Ready for a Comeback IPO
Verisure, Europe's leading monitored alarm provider, is preparing a comeback IPO in 2025 that could be one of the year's most significant listings.
16 Sep 2025
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
Ticker symbol
524636
Country
🇮🇳 India